期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Pattern and Risk Factors of Liver Injury among Hospitalized Covid-19 Patients:The Experience of a Greek Referral Hospital
1
作者 Anastasia Tsatsa maria mela +6 位作者 Ioannis Kalomenidis Artemis Trikola Georgios Karampekos Christina Chatzievangelinou Georgios Filippidis Marina Vraka Gerassimos J.Mantzaris 《Journal of Pharmacy and Pharmacology》 CAS 2021年第12期406-413,共8页
Background:Although the new coronavirus(SARS-COV-2)affects predominantly the respiratory system,concomitant liver manifestations are common among COVID-19 patients.Aim:To investigate the prevalence and pattern of live... Background:Although the new coronavirus(SARS-COV-2)affects predominantly the respiratory system,concomitant liver manifestations are common among COVID-19 patients.Aim:To investigate the prevalence and pattern of liver impairment(hepatocellular,cholestatic,mixed)and identify risk factors potentially associated with the liver injury in hospitalized patients with Covid-19.Materials and Methods:This retrospective study enrolled consecutive patients with Covid-19 who had evidence of liver injury on admission and/or during hospitalization in a tertiary hospital.Patient demographic,clinical and laboratory data were captured from the hospital’s electronic data monitoring system.Univariate and multivariate logistic regression analysis were applied to identify risk factors for liver injury.Results:Overall,of the 113 hospitalized Covid-19 patients,73(64.6%)patients had evidence of liver injury.Admission to Intensive Care Unit and length of in-hospital stay were identified as independent risk factors for liver injury by multivariate analysis(p=0.014 and p=0.001,respectively).35 patients(47.9%)had hepatocellular and 18 patients(24.7%)had cholestatic liver injury.Admission to Intensive Care Unit was statistically significantly associated with hepatocellular injury(p=0.006).Conclusions:Liver injury is common in hospitalized Covid-19 patients.Hepatocellular-type injury is more common and is associated with a more severe course of disease. 展开更多
关键词 SARS-COV-2 COVID-19 hepatocellular injury cholestatic injury
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部